Individuals on Tirzepatide (n = 50) reported a median dose of 7.5 mg [range 0.515 mg], and on Semaglutide variants: Ozempic or Wegovy (n = 54) reported a median dose of 1 [range 0.252.4] and Rybelsus (n = 2) reported doses of 7 mg and 14 mg
A large observational study published in mid-2025 reported that diabetic patients using GLP-1 drugs experienced a two- to threefold increased risk of developing nAMD compared to non-users
Her announcement sparked a lot of chatter amongst different groups, driving the message that even world class athletes with disciplined workout routines may need to turn to GLP-1s for their needs
TRPM7 elicits its effects by triggering Ca 2+ influx in response to fluid shear, thereby activating RhoA-dependent contractility and the calmodulin/IQGAP1/Cdc42 pathway [220]
Research applications include GHS-R1a pharmacology, receptor activation kinetics, signaling pathway characterization, structure-activity relationship investigations, and comparative analyses of growth hormone secretagogue receptor ligands
Side effects of retatrutide The most frequently reported side effects associated with retatrutide treatment are gastrointestinal, including nausea, vomiting, diarrhoea, and constipation